RBC Capital Maintains Outperform on AdaptHealth, Lowers Price Target to $13
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Ben Hendrix has maintained an 'Outperform' rating on AdaptHealth (NASDAQ:AHCO), but lowered the price target from $18 to $13.

November 08, 2023 | 7:24 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
AdaptHealth's price target has been lowered from $18 to $13 by RBC Capital, though the 'Outperform' rating is maintained.
The lowering of the price target by RBC Capital could potentially create a negative sentiment among investors, which may put downward pressure on the stock price. However, the maintained 'Outperform' rating indicates that the analyst still sees potential upside, which could counterbalance the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100